TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Lab Pharma AS
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
29,367
|
21,730
|
21,903 |
| Financial expenses |
1,390
|
500
|
1,035 |
| Earnings before taxes |
2,118
|
-847
|
-1,146 |
| Total assets |
8,971
|
4,765
|
4,713 |
| Current assets |
6,909
|
2,267
|
2,387 |
| Current liabilities |
7,301
|
4,747
|
4,034 |
| Equity capital |
1,670
|
18
|
679 |
| - share capital |
500
|
500
|
500 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
18.6%
|
0.4%
|
14.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
-3.9%
|
-5.2% |
| Return on assets (ROA) |
39.1%
|
-7.3%
|
-2.4% |
| Current ratio |
94.6%
|
47.8%
|
59.2% |
| Return on equity (ROE) |
126.8%
|
-4705.6%
|
-168.8% |
| Change turnover |
7,637
|
-173
|
-10,656 |
| Change turnover % |
35%
|
-1%
|
-33% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.